AxoGen Inc (AXGN)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:AxoGen Inc (AXGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011902
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions for peripheral nerve injuries. The company offers AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products. It also offers clinical research studies in understanding and outcome of peripheral nerve regeneration and reconstruction projects. AxoGen’s clinical research programs comprise the CHANGE study, the RANGER study, and the RECON study programs. The company sells its products through a network of distributors in the US and abroad. AxoGen is headquartered in Alachua, Florida, the US.

AxoGen Inc (AXGN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AxoGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AxoGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AxoGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AxoGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AxoGen Inc, Medical Devices Deals, 2011 to YTD 2017 9
AxoGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AxoGen Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
AxoGen Plans to Raise up to USD92.2 Million in Public Offering of Shares 11
AxoGen Raises USD17.5 Million in Private Placement of Shares 12
AxoGen Raises USD15 Million in Public Offering of Shares 14
AxoGen Inc – Key Competitors 15
AxoGen Inc – Key Employees 16
AxoGen Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Nov 01, 2017: AxoGen Reports 2017 Third Quarter Financial Results 18
Aug 02, 2017: AxoGen Reports 2017 Second Quarter Financial Results 19
May 04, 2017: AxoGen Reports 2017 First Quarter Financial Results 20
Feb 22, 2017: AxoGen Reports 2016 Fourth Quarter and Full Year Financial Results 21
Jan 09, 2017: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2016 Revenue 23
Nov 02, 2016: AxoGen Reports Financial Results for Third Quarter 2016 24
Aug 03, 2016: AxoGen Reports Financial Results for Second Quarter 2016 25
May 04, 2016: AxoGen First Quarter Revenue Increases 64% Over Prior Year to $8.1 Million 26
Corporate Communications 27
Jul 17, 2017: AxoGen Appoints Jon Gingrich Chief Commercial Officer 27
Sep 19, 2016: AxoGen Appoints Amy Wendell to Board of Directors 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
AxoGen Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
AxoGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AxoGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AxoGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AxoGen Inc, Deals By Therapy Area, 2011 to YTD 2017 8
AxoGen Inc, Medical Devices Deals, 2011 to YTD 2017 9
AxoGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AxoGen Plans to Raise up to USD92.2 Million in Public Offering of Shares 11
AxoGen Raises USD17.5 Million in Private Placement of Shares 12
AxoGen Raises USD15 Million in Public Offering of Shares 14
AxoGen Inc, Key Competitors 15
AxoGen Inc, Key Employees 16
AxoGen Inc, Other Locations 17
AxoGen Inc, Subsidiaries 17

★海外企業調査レポート[AxoGen Inc (AXGN)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Purepoint Uranium Group Inc (PTU):企業の財務・戦略的SWOT分析
    Purepoint Uranium Group Inc (PTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Roper Technologies Inc (ROP):企業の財務・戦略的SWOT分析
    Roper Technologies Inc (ROP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • HSC Technology Group Ltd (HSC):企業の財務・戦略的SWOT分析
    HSC Technology Group Ltd (HSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Zweites Deutsches Fernsehen:企業の戦略的SWOT分析
    Zweites Deutsches Fernsehen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Sasol Ltd (SOL):企業の財務・戦略的SWOT分析
    Sasol Ltd (SOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Pakistan Petroleum Limited (PPL)-石油・ガス分野:企業M&A・提携分析
    Summary Pakistan Petroleum Limited (PPL) is an upstream oil and gas company. It explores, develops and produces crude oil and natural gas resources. The company produces crude oil, natural gas, natural gas liquids, liquefied petroleum gas and barytes. It operates producing fields in Sui, Kandhkot, A …
  • Coca-Cola HBC-Srbija d.o.o.:企業の戦略・SWOT・財務情報
    Coca-Cola HBC-Srbija d.o.o. - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola HBC-Srbija d.o.o. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Allena Pharmaceuticals Inc (ALNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Allena Pharmaceuticals Inc (Allena) is a developer of oral enzyme therapeutics to treat patients with rare and severe metabolic disorders. The company develops ALLN-177, an oral recombinant oxalate degrading enzyme. It provides ALLN-177 which is developed for the chronic management of hypero …
  • Tikcro Technologies Ltd (TIKRF):企業の財務・戦略的SWOT分析
    Summary Tikcro Technologies Ltd (Tikcro) is a biotechnology company that discovers, develops, manufactures and markets antibodies. The company undertakes clinical trials for its pipeline products PD1, PDL1, PDL2, TIGIT and CTLA-4 products, among others. Tikcro products are based on 3D antigens desig …
  • British Columbia Cancer Agency:製薬・医療:M&Aディール及び事業提携情報
    Summary British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as diagnostic and therapy planning, radiation therapy, patient assessment …
  • JM AB:企業の戦略・SWOT・財務情報
    JM AB - Strategy, SWOT and Corporate Finance Report Summary JM AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • NCC AB:企業の戦略・SWOT・財務情報
    NCC AB - Strategy, SWOT and Corporate Finance Report Summary NCC AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Litani River Authority:企業の戦略的SWOT分析
    Litani River Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sanquin Blood Supply Foundation:企業の戦略的SWOT分析
    Sanquin Blood Supply Foundation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • PG&E Corp (PCG):企業の財務・戦略的SWOT分析
    PG&E Corp (PCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • FluoroPharma Medical Inc (FPMI):企業の財務・戦略的SWOT分析
    Summary FluoroPharma Medical Inc (FluoroPharma) is a molecular imaging company that develops and commercialize proprietary medical diagnostic imaging products. The company develops breakthrough positron emission tomography imaging agents for the assessment and detection of acute and chronic forms of …
  • Shinsei Bank Ltd:戦略・SWOT・企業財務分析
    Shinsei Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Shinsei Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ulthera Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ulthera Inc (Ulthera), a subsidiary of Merz Pharma GmbH & Co KgaA is a medical device company that develops and commercializes technologies for aesthetic and medical applications by using its therapeutic ultrasound platform technologies. The company’s therapeutic ultrasound platform technolo …
  • True Value Company:企業の戦略・SWOT・財務情報
    True Value Company - Strategy, SWOT and Corporate Finance Report Summary True Value Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Britannia Industries Limited:企業の戦略・SWOT・財務情報
    Britannia Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Britannia Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆